Attached is a new GMVEMSC Just in Time Standing Order (JITSO).  This is for optional use by EMS agencies to administer an additional monoclonal antibody (mAb) treatment.  We previously issued a JITSO for a mAb called Regeneron.  The new JITSO is for sotrovimab, which is more effective with the Omicron variant.  Treatment with mAbs can reduce risk of hospitalization or death due to COVID-19 by more than 70%. 

This JITSO includes the lessons learned by EMS agencies in our area using the Regeneron JITSO.  As before, if your agency chooses to do so, this JITSO can be used in several settings:

• In congregate residential sites, especially those experiencing COVID-19 outbreaks.  This can help reduce EMS run volumes;
• In homes and other locations.  For some agencies, Community Paramedicine programs may be used in those settings (treatment and PEP);
• Other settings such as regional locations during major surges.

If you haven’t already and your agency would consider delivering mAbs, fill out this very short survey:  https://www.surveymonkey.com/r/JCT3F6N.  Completion of the survey does not obligate your agency to ANYTHING.

Information brought to you by Dayton MMRS with approval from Dr. Marriott, Region 3 RPAB Chair.  We gratefully acknowledge the help and support of GMVEMSC, and public health, public safety, emergency management and other agencies and individuals throughout the region. 

David N. Gerstner

                           MMRS/RMRS/EP Coordinator

                           Department of Fire  I  City of Dayton

                           300 N. Main St.  I  Dayton, Ohio 45402

       Office 937.333.4551  I  Fax 937.333.4561  I  www.daytonohio.gov

       24/7 Pager: 937-227-8705 or E-mail 9372278705@archwireless.net
       Cell  937.776.4410

david.gerstner@daytonohio.gov I  http://DaytonMMRS.org